Abstract
The ACR2 gene of Saccharomyces cerevisiae was disrupted by insertion of a HIS3 gene. Cells with the disruption were sensitive to arsenate. This phenotype could be complemented by ACR2 on a plasmid. The ACR2 gene was cloned and expressed in Escherichia coli as a malE gene fusion with a C-terminal histidine tag. The combination of chimeric MBP-Acr2-6H protein and yeast cytosol from an ACR2-disrupted strain exhibited arsenate reductase activity.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adenosine Triphosphatases / genetics*
-
Adenosine Triphosphatases / metabolism
-
Arsenate Reductases
-
Arsenates / pharmacology
-
Arsenite Transporting ATPases
-
Artificial Gene Fusion
-
Drug Resistance, Microbial / genetics
-
Escherichia coli
-
Genes, Fungal*
-
Genetic Complementation Test
-
Ion Pumps*
-
Multienzyme Complexes*
-
Plasmids
-
Recombinant Fusion Proteins
-
Saccharomyces cerevisiae / drug effects
-
Saccharomyces cerevisiae / enzymology
-
Saccharomyces cerevisiae / genetics*
-
Saccharomyces cerevisiae Proteins
Substances
-
Arsenates
-
Ion Pumps
-
Multienzyme Complexes
-
Recombinant Fusion Proteins
-
Saccharomyces cerevisiae Proteins
-
ARR2 protein, S cerevisiae
-
Arsenate Reductases
-
Adenosine Triphosphatases
-
Arsenite Transporting ATPases